SYNOPSIS

Increasing health consciousness and preventive care have changed the landscape of

healthcare services market in more ways than one. Whether it is wellness checkups,

preventive care checkups or insurance-related checkups, diagnostics and pathology

laboratories are growing significantly, fuelled by the growth in outsourcing diagnostics tests

and clinical research. Diagnostics and pathology lab test services market in India holds 44%

of the medical devices and diagnostics  market, valued at INR125.87 billion in 2007.

According to estimates, Indian diagnostic and pathological labs test services market

is valued at INR55.9 billion (2007) and is estimated to reach INR139 billion by 2012.

The report has tremendous significance in view of the present spurt in healthcare expenses

due to growing awareness of healthcare and disease burden. This report gives a broad picture

of the diagnostic and pathology laboratory industry, trends in the market, major players and

their future growth plans and strategies, major growth triggers, issues and challenges, critical

success factors, regulations and accreditation and future outlook of the industry. The report

will be useful to investors interested in setting up path laboratory chain in India, all those

associated with healthcare industry, medical devices and diagnostics equipment

manufacturers, foreign investors, industry analysts, and students interested in Indian

healthcare industry. 

目录及图表

No of Pages: 51 

No of Chapters: 7 

No of Annexures: 2

No of Tables: 2  

No of Figures: 10 

EXECUTIVE SUMMARY...............................................................................................8

HIGHLIGHTS.............................................................................................................10

1. INDUSTRY & MARKET OVERVIEW........................................................................12

1.1 Global medical and diagnostics laboratory ...............................................12

1.2 Indian healthcare industry..............................................................................13

1.2.2 Healthcare infrastructure .........................................................................14

1.2.3 Overview of diagnostics & pathology laboratory Industry.................14

1.2.3.1 Industry structure.................................................................................15

1.2.3.2 Industry classification .........................................................................16

1.2.3.3 Therapeutic segments .......................................................................17

1.3.4 Existing Business Models ............................................................................17

2. ACCREDITATIONS & QUALITY CONTROL ...........................................................19

2.1 Introduction.......................................................................................................19

2.2 National Accreditation Board for Testing & Calibration Laboratories.....19

2.3 College for American Pathologist .................................................................20

2.3.1 Benefits of CAP Accreditation.................................................................21

2.4 Effect of the accreditation process among the clinical labs ...................21

2.4.1 Quality manual ..........................................................................................21

2.4.2 Quality System Procedure........................................................................21

2.4.3 Standard Test Operating Procedure (SOP) ...........................................22

2.4.4 Records .......................................................................................................22

2.4.5. Quality control (Interlab/external).........................................................22

2.4.6. Internal audit .............................................................................................22

2.4.7. Overall cost/expenses for Audit.............................................................22

3. MAJOR PLAYERS .................................................................................................23

3.1 Introduction.......................................................................................................23

3.2 Metropolis ..........................................................................................................23

3.2.1. Company Background ...........................................................................23

3.2.2. Contact Address ......................................................................................24

3.2.3 Management Team..................................................................................24

3.2.4. Infrastructure & Accreditations ..............................................................24

3.2.4.1 Infrastructure .......................................................................................24

3.2.4.2 Accreditations.....................................................................................24

3.2.5. Business Strategy & Competitive Advantages ....................................24

3.2.5.1 Strategies .............................................................................................24

3.2.5.2 Competitive Advantages .................................................................25

3.2.6. Outlook.......................................................................................................25

3.3 SRL Ranbaxy......................................................................................................26

3.3.1. Company Background ...........................................................................26

3.3.2. Contact Address ......................................................................................26

3.3.3. Management Team.................................................................................27

3.3.4. Infrastructure & Accreditations ..............................................................27

3.3.4.1 Infrastructure .......................................................................................27

3.3.4.2 Accreditations.....................................................................................27

3.3.5. Business Strategy & Competitive Advantages ....................................27

3.3.5.1 Strategies .............................................................................................27

3.3.5.2 Competitive Advantages .................................................................28

3.3.6. Outlook.......................................................................................................28

3.4 Wellspring ..........................................................................................................29

3.4.1. Company Background ...........................................................................29

3.4.2. Contact Address: .....................................................................................29

3.4.3. Management Team.................................................................................29

3.4.4. Infrastructure & Accreditations ..............................................................30

3.4.4.1 Infrastructure .......................................................................................30

3.4.4.2 Accreditations.....................................................................................30

3.4.5. Business Strategy & Competitive Advantages ....................................30

3.4.5.1 Strategies .............................................................................................30

3.4.5.2 Competitive Advantages .................................................................30

3.4.6. Outlook.......................................................................................................30

3.5 Dr Lal PathLabs .................................................................................................31

3.5.1. Company Background ...........................................................................31

3.5.2. Contact Address ......................................................................................31

3.5.3. Management Team.................................................................................32

3.5.4. Infrastructure & Accreditations ..............................................................32

3.5.4.1 Infrastructure .......................................................................................32

3.5.4.2 Accreditations.....................................................................................32

3.5.5. Business Strategy & Competitive Advantages ....................................32

3.5.5.1 Strategies .............................................................................................32

3.5.5.2 Competitive Advantages .................................................................32

3.5.6. Outlook.......................................................................................................33

3.6 Thyrocare...........................................................................................................34

3.6.1. Company Background ...........................................................................34

3.6.2. Contact Address ......................................................................................34

3.6.3. Management Team.................................................................................34

3.6.4. Infrastructure & Accreditations ..............................................................35

3.6.4.1 Infrastructure .......................................................................................35

3.6.4.2 Accreditations.....................................................................................35

3.6.5. Business Strategy & Competitive Advantages ....................................35

3.6.5.1 Strategies .............................................................................................35

3.6.5.2 Competitive Advantages .................................................................35

3.6.6. Outlook.......................................................................................................35

3.7 Anand Labs.......................................................................................................36

3.7.1. Company Background ...........................................................................36

3.7.2. Contact Address ......................................................................................36

3.7.3. Management Team.................................................................................36

3.7.4. Infrastructure & Accreditations ..............................................................37

3.7.4.1 Infrastructure .......................................................................................37

3.7.4.2 Accreditations.....................................................................................37

3.7.5. Business Strategy & Competitive Advantages ....................................37

3.7.5.1 Strategies .............................................................................................37

3.7.5.2 Competitive Advantages .................................................................37

3.7.6. Outlook.......................................................................................................37

4. GROWTH DRIVERS ...............................................................................................38

4.1 Introduction.......................................................................................................38

4.2 Healthcare Institutes ........................................................................................38

4.2.1 Foreign hospitals outsourcing diagnostics tests ....................................38

4.2.2 Polyclinics....................................................................................................39

4.2.3 Pharmacies.................................................................................................39

5.2.4 Medical KPO ..............................................................................................39

4.3 Healthcare Services.........................................................................................39

4.3.1 CRO.............................................................................................................39

4.3.2 Molecular diagnostics ..............................................................................40

4.3.3 Pharmacogenomics .................................................................................40

4.4 Theranostics, driving diagnostic test in drug development ......................40

4.5 Logistics and Infrastructure.............................................................................41

4.6 IT Infrastructure and Network .........................................................................41

4.7 Insurance...........................................................................................................41

5. CRITICAL SUCCESS FACTORS.............................................................................42

5.1 Automation and standardisation..................................................................42

5.2 Success of tests.................................................................................................42

5.3 Processing blood samples ..............................................................................42

5.4 Laboratory accreditation ...............................................................................43

6. ISSUES AND CHALLENGES ..................................................................................44

6.1 Regulatory issues ..............................................................................................44

6.2 Reimbursement pressures ...............................................................................44

6.3 Analytical and quality issues ..........................................................................44

6.4 Accreditation procurement ...........................................................................45

7. FUTURE OUTLOOK................................................................................................46

ANNEXURE I.............................................................................................................48

ANNEXURE II............................................................................................................50